Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.

Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

Data from the Phase 3 PALOMA-3 study showed non-inferiority to intravenous administration meeting both co-primary pharmacokinetic (PK) endpoints, as well as a five-fold reduction in infusion-related ...

Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease.

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, ...

Notably, GPT-4 demonstrated high sensitivity in the classification of adenocarcinomas, indicating its potential utility in specific cancer diagnostic contexts. As a large language model, GPT-4 shows ...

Jan 21 (Reuters) - Atara Biotherapeutics (ATRA.O), opens new tab said on Tuesday the U.S. health regulator had placed a clinical hold on its trials for cancer cell therapies, sending the drug ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...